Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma
•Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min. Sphingolipids are a family of bioactive mol...
Saved in:
Published in | Journal of Chromatography A Vol. 1320; pp. 103 - 110 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
13.12.2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min.
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r2>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease. |
---|---|
AbstractList | •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min.
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r2>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease. Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r²>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease. Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5-4 orders of magnitude (r(2)>0.99), a limit of detection of 0.01-0.17pmol/mL, and a limit of quantitation of 0.02-0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6-95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease. Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10 min. A broad linear range over 2.5-4 orders of magnitude (r2 > 0.99), a limit of detection of 0.01-0.17 pmol/mL, and a limit of quantitation of 0.02-0.42 pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6-95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease. |
Author | Dai, Weidong Li, Jia Zhao, Xinjie Hu, Chunxiu Lu, Xin Chen, Shili Xu, Guowang |
Author_xml | – sequence: 1 givenname: Jia surname: Li fullname: Li, Jia – sequence: 2 givenname: Chunxiu surname: Hu fullname: Hu, Chunxiu – sequence: 3 givenname: Xinjie surname: Zhao fullname: Zhao, Xinjie – sequence: 4 givenname: Weidong surname: Dai fullname: Dai, Weidong – sequence: 5 givenname: Shili surname: Chen fullname: Chen, Shili – sequence: 6 givenname: Xin surname: Lu fullname: Lu, Xin – sequence: 7 givenname: Guowang surname: Xu fullname: Xu, Guowang email: xugw@dicp.ac.cn |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27975654$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24210299$$D View this record in MEDLINE/PubMed |
BookMark | eNqNksuO1DAQRSM0iHnAHyDkDRKbNLbjvGaBNBrxkhqxgXXk2OWOW47tsZ1B_b98CM50AxILYBWndO6t0q26LM6ss1AUzwneEEya1_uNmIKb-YZiUuXSBjfsUXFBurYqq7btzooLjCkp-6atzovLGPcYkxa39ElxThklmPb9RfF9y8MOyii4AYmmZeYWRQjLjKKftN05o72WyAentMn_aDygJa6PAPcQIsjSTzwCMvpuyeBxpuR2gfvpgIRb_Gr8TacJyYPlsxZoXkzSuZwtuEjaWTQ7q5MLq61TaOYx5vYgUvaCFA7X6BOkyUkkc0_j_Aw2IW4l4t4bLfiDh7ZoAp9bCzBmMTwgwYPQNo_ztHisuInw7PS9Kr6-e_vl9kO5_fz-4-3NthSs7lLZdLIHyWtJFZVcdUKwrpZNT8exHhWthCI53boaSSeUANV0WcFaEA1mqm-huipeHX1zXHcLxDTMOq7jcAtuiQNpesb6irX9f6BVjWnNGprRFyd0GWeQgw965uEw_FxiBl6eAL7uUQVuhY6_ubZv66ZmmWNHTgQXYwD1CyF4WG9q2A_H_Q3rTa3VfFNZdv2HTOj0kHkKXJt_id8cxZBzv9cQhig0WAFSh7zgQTr9d4Mfkn7yOg |
CODEN | JOCRAM |
CitedBy_id | crossref_primary_10_1007_s00280_018_3655_z crossref_primary_10_1021_acs_jproteome_8b00270 crossref_primary_10_1152_ajpgi_00153_2014 crossref_primary_10_1007_s41664_017_0028_2 crossref_primary_10_1039_C5RA09429A crossref_primary_10_1016_j_ejca_2016_10_011 crossref_primary_10_1038_s41564_023_01561_1 crossref_primary_10_3390_ijms23094477 crossref_primary_10_1021_ac5009964 crossref_primary_10_1016_j_chroma_2016_07_008 crossref_primary_10_1158_1055_9965_EPI_21_0687 crossref_primary_10_1016_j_aca_2020_09_060 crossref_primary_10_1007_s00216_016_9775_6 crossref_primary_10_1021_acs_analchem_8b01331 crossref_primary_10_1039_C7AY01922J crossref_primary_10_1021_acs_analchem_0c04756 crossref_primary_10_3390_biom12050709 crossref_primary_10_1016_j_chroma_2015_01_013 crossref_primary_10_1016_j_jalz_2017_01_008 crossref_primary_10_1016_j_talanta_2021_123006 crossref_primary_10_1016_j_aca_2023_342115 crossref_primary_10_1002_bmc_4094 crossref_primary_10_1007_s00216_021_03853_z crossref_primary_10_18632_oncotarget_23494 crossref_primary_10_1021_acs_jproteome_5b00841 crossref_primary_10_1016_j_bbalip_2014_04_008 crossref_primary_10_1021_acs_jafc_8b02706 crossref_primary_10_3390_molecules23061324 crossref_primary_10_1016_j_jchromb_2021_122684 crossref_primary_10_1016_j_jchromb_2019_03_008 crossref_primary_10_1016_j_aca_2019_02_021 crossref_primary_10_1016_j_jchromb_2020_122289 crossref_primary_10_1371_journal_pone_0131569 |
Cites_doi | 10.4161/cbt.11.2.14624 10.1016/j.ymeth.2005.01.009 10.1016/j.chroma.2013.04.016 10.1002/rcm.1373 10.1016/j.chroma.2013.05.019 10.1016/j.jchromb.2009.07.008 10.1210/er.2007-0025 10.1194/jlr.R800073-JLR200 10.1194/jlr.D000430 10.1194/jlr.D008532 10.1021/pr070183p 10.1194/jlr.D800051-JLR200 10.1194/jlr.E400004-JLR200 10.1021/ac202646v 10.1016/j.ab.2012.01.027 10.1194/jlr.R003996 10.1016/j.chemphyslip.2011.04.013 10.2174/187152012800228643 10.1007/s11745-011-3633-2 10.1074/jbc.R000005200 10.1021/cr2002917 10.1021/pr800373m 10.2217/fon.10.116 10.1194/jlr.D005322 10.1016/j.ab.2005.01.058 10.1007/s10555-011-9304-1 10.1007/s12272-009-2219-5 10.1007/s00018-007-7076-0 10.1038/nrm2329 10.1016/j.ab.2007.08.019 10.1016/j.bbalip.2011.05.011 10.1373/clinchem.2006.079012 10.1139/o59-099 10.1194/jlr.D700041-JLR200 10.1016/j.jchromb.2006.06.025 10.1016/j.ymeth.2006.05.004 10.1016/j.bbalip.2010.11.003 10.1016/j.jchromb.2013.03.019 10.1016/j.ab.2010.02.023 10.1038/nrc1411 10.1006/abio.2001.5108 |
ContentType | Journal Article |
Copyright | 2013 Elsevier B.V. 2015 INIST-CNRS Copyright © 2013 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2013 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2013 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QH 7UA C1K F1W H97 L.G 7S9 L.6 |
DOI | 10.1016/j.chroma.2013.10.064 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Aqualine Water Resources Abstracts Environmental Sciences and Pollution Management ASFA: Aquatic Sciences and Fisheries Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Aquatic Science & Fisheries Abstracts (ASFA) Professional AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Aquatic Science & Fisheries Abstracts (ASFA) Professional Aqualine Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality ASFA: Aquatic Sciences and Fisheries Abstracts Water Resources Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE Aquatic Science & Fisheries Abstracts (ASFA) Professional |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1873-3778 |
EndPage | 110 |
ExternalDocumentID | 24210299 27975654 10_1016_j_chroma_2013_10_064 S002196731301683X |
Genre | Validation Studies Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABFNM ABFRF ABJNI ABMAC ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADECG ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFZHZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FLBIZ FNPLU FYGXN G-Q GBLVA IH2 IHE J1W KOM M36 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SCH SDF SDG SDP SES SPC SPCBC SSK SSZ T5K WH7 XPP YK3 ZMT ~02 ~G- ~KM .GJ 29K AAHBH AATTM AAXKI AAYJJ AAYWO AAYXX ABDPE ACNNM ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AFXIZ AGCQF AGRNS AI. AIGII AIIUN AJQLL AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION D-I FEDTE FGOYB HMU HVGLF HZ~ H~9 OHT SCB SEW SSH UQL VH1 WUQ ZGI ZKB ZXP IQODW CGR CUY CVF ECM EIF NPM 7QH 7UA C1K F1W H97 L.G 7S9 L.6 |
ID | FETCH-LOGICAL-c458t-68d9eda5d2f2daf8cc485d692bb5bf23cf118753b18cfcef6868d47ec604f97e3 |
IEDL.DBID | .~1 |
ISSN | 0021-9673 |
IngestDate | Fri Jul 11 11:03:27 EDT 2025 Fri Jul 11 16:07:00 EDT 2025 Thu Jan 02 22:11:40 EST 2025 Wed Apr 02 07:35:46 EDT 2025 Tue Jul 01 00:46:47 EDT 2025 Thu Apr 24 23:02:29 EDT 2025 Fri Feb 23 02:33:23 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Tert-butyl methyl ether Sphingolipid profiling Multiple reaction monitoring MRM Lipidomics Sph APCI dHCer MTBE Cer RPLC HexCer LacCer Serum SM ESI Liquid chromatography–mass spectrometry NPLC HILIC Ultra performance liquid chromatography Biological fluid Tandem mass spectrometry Chemical analysis Biological marker Lipids Hepatic disease Hepatocellular carcinoma Solvent extraction Electrospray Blood Sample preparation Quantitative analysis Human Validation Healthy subject Liquid liquid extraction Coupled method Multiple reaction monitoring mode Liquid chromatography-mass spectrometry Sphingolipid Patient Malignant tumor Reversed phase chromatography Digestive diseases Blood serum Chemometrics Cancer Principal component analysis electrospray ionization ceramide hydrophilic interaction liquid chromatography reversed phase liquid chromatography normal phase liquid chromatography hexosylceramide dihydroceramide lactosylceramide free sphingoid base atmospheric-pressure chemical ionization sphingomyelin |
Language | English |
License | CC BY 4.0 Copyright © 2013 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c458t-68d9eda5d2f2daf8cc485d692bb5bf23cf118753b18cfcef6868d47ec604f97e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24210299 |
PQID | 1635025462 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1694493479 proquest_miscellaneous_1635025462 pubmed_primary_24210299 pascalfrancis_primary_27975654 crossref_primary_10_1016_j_chroma_2013_10_064 crossref_citationtrail_10_1016_j_chroma_2013_10_064 elsevier_sciencedirect_doi_10_1016_j_chroma_2013_10_064 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-12-13 |
PublicationDateYYYYMMDD | 2013-12-13 |
PublicationDate_xml | – month: 12 year: 2013 text: 2013-12-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Journal of Chromatography A |
PublicationTitleAlternate | J Chromatogr A |
PublicationYear | 2013 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Matyash, Liebisch, Kurzchalia, Shevchenko, Schwudke (bib0130) 2008; 49 Kolter (bib0040) 2011; 164 Lee, Choi, Choi, Ji, Yoo, Lee, Hong, Yun, Yoo (bib0065) 2009; 32 Jiang, Cheng, Yang, Gross, Han (bib0160) 2007; 371 Furuya, Shimizu, Kawamori (bib0190) 2011; 30 Ponnusamy, Meyers-Needham, Senkal, Saddoughi, Sentelle, Selvam, Salas, Ogretmen (bib0195) 2010; 6 Bui, Leohr, Kuo (bib0110) 2012; 423 Farwanah, Kolter, Sandhoff (bib0185) 2011; 1811 He, Chen, Gatt, Schuchman (bib0055) 2001; 293 Scherer, Boettcher, Schmitz, Liebisch (bib0155) 2011; 1811 Liang, Wu, Sun, Wang, Hou, Yang, Jiang, Liu, Guo (bib0175) 2013; 1294 Pettus, Kroesen, Szulc, Bielawska, Bielawski, Hannun, Busman (bib0145) 2004; 18 Fahy, Subramaniam, Brown, Glass, Merrill, Murphy, Raetz, Russell, Seyama, Shaw, Shimizu, Spener, van Meer, VanNieuwenhze, White, Witztum, Dennis (bib0005) 2005; 46 Hannun, Obeid (bib0025) 2008; 9 Farwanah, Wirtz, Kolter, Raith, Neubert, Sandhoff (bib0090) 2009; 877 Delgado, Fabrias, Bedia, Casas, Abad (bib0205) 2012; 12 Groener, Poorthuis, Kuiper, Helmond, Hollak, Aerts (bib0070) 2007; 53 Hu, van Dommelen, van der Heijden, Spijksma, Reijmers, Wang, Slee, Lu, Xu, van der Greef, Hankemeier (bib0135) 2008; 7 Shaner, Allegood, Park, Wang, Kelly, Haynes, Sullards, Merrill (bib0095) 2009; 50 Merrill (bib0030) 2011; 111 Ryland, Fox, Liu, Loughran, Kester (bib0045) 2011; 11 Scherer, Leuthaeuser-Jaschinski, Ecker, Schmitz, Liebisch (bib0105) 2010; 51 He, Dagan, Gatt, Schuchman (bib0060) 2005; 340 Gika, Theodoridis, Wingate, Wilson (bib0140) 2007; 6 Bielawski, Szulc, Hannun, Bielawska (bib0085) 2006; 39 Bligh, Dyer (bib0125) 1959; 37 Yoo, Son, Kim (bib0075) 2006; 843 Yan, Li, Lv, Li, Zhou, Yang (bib0180) 2013; 928 Oskouian, Saba (bib0210) 2010 Merrill, Stokes, Momin, Park, Portz, Kelly, Wang, Sullards, Wang (bib0010) 2009; 50 Ogretmen, Hannun (bib0200) 2004; 4 t’Kindt, Jorge, Dumont, Couturon, David, Sandra, Sandra (bib0165) 2012; 84 Holland, Summers (bib0035) 2008; 29 Kasumov, Huang, Chung, Zhang, McCullough, Kirwan (bib0100) 2010; 401 Merrill, Sullards, Allegood, Kelly, Wang (bib0080) 2005; 36 Masood, Rao, Acharya, Blonder, Veenstra (bib0115) 2012; 47 Chen, Hoene, Li, Li, Zhao, Haring, Schleicher, Weigert, Xu, Lehmann (bib0170) 2013; 1298 Brown, London (bib0015) 2000; 275 Lahiri, Futerman (bib0020) 2007; 64 Xu, Barnes, Sun, Grabowski (bib0050) 2010; 51 Wijesinghe, Allegood, Gentile, Fox, Kester, Chalfant (bib0120) 2010; 51 Hammad, Pierce, Soodavar, Smith, Al Gadban, Rembiesa, Klein, Hannun, Bielawski, Bielawska (bib0150) 2010; 51 Delgado (10.1016/j.chroma.2013.10.064_bib0205) 2012; 12 Ponnusamy (10.1016/j.chroma.2013.10.064_bib0195) 2010; 6 He (10.1016/j.chroma.2013.10.064_bib0060) 2005; 340 Gika (10.1016/j.chroma.2013.10.064_bib0140) 2007; 6 Merrill (10.1016/j.chroma.2013.10.064_bib0080) 2005; 36 Merrill (10.1016/j.chroma.2013.10.064_bib0030) 2011; 111 t’Kindt (10.1016/j.chroma.2013.10.064_bib0165) 2012; 84 Scherer (10.1016/j.chroma.2013.10.064_bib0105) 2010; 51 Brown (10.1016/j.chroma.2013.10.064_bib0015) 2000; 275 Chen (10.1016/j.chroma.2013.10.064_bib0170) 2013; 1298 Bligh (10.1016/j.chroma.2013.10.064_bib0125) 1959; 37 Lee (10.1016/j.chroma.2013.10.064_bib0065) 2009; 32 Ogretmen (10.1016/j.chroma.2013.10.064_bib0200) 2004; 4 Farwanah (10.1016/j.chroma.2013.10.064_bib0090) 2009; 877 Yan (10.1016/j.chroma.2013.10.064_bib0180) 2013; 928 Kolter (10.1016/j.chroma.2013.10.064_bib0040) 2011; 164 He (10.1016/j.chroma.2013.10.064_bib0055) 2001; 293 Bui (10.1016/j.chroma.2013.10.064_bib0110) 2012; 423 Kasumov (10.1016/j.chroma.2013.10.064_bib0100) 2010; 401 Wijesinghe (10.1016/j.chroma.2013.10.064_bib0120) 2010; 51 Pettus (10.1016/j.chroma.2013.10.064_bib0145) 2004; 18 Lahiri (10.1016/j.chroma.2013.10.064_bib0020) 2007; 64 Holland (10.1016/j.chroma.2013.10.064_bib0035) 2008; 29 Hu (10.1016/j.chroma.2013.10.064_bib0135) 2008; 7 Jiang (10.1016/j.chroma.2013.10.064_bib0160) 2007; 371 Oskouian (10.1016/j.chroma.2013.10.064_bib0210) 2010 Furuya (10.1016/j.chroma.2013.10.064_bib0190) 2011; 30 Hannun (10.1016/j.chroma.2013.10.064_bib0025) 2008; 9 Hammad (10.1016/j.chroma.2013.10.064_bib0150) 2010; 51 Yoo (10.1016/j.chroma.2013.10.064_bib0075) 2006; 843 Matyash (10.1016/j.chroma.2013.10.064_bib0130) 2008; 49 Xu (10.1016/j.chroma.2013.10.064_bib0050) 2010; 51 Bielawski (10.1016/j.chroma.2013.10.064_bib0085) 2006; 39 Shaner (10.1016/j.chroma.2013.10.064_bib0095) 2009; 50 Scherer (10.1016/j.chroma.2013.10.064_bib0155) 2011; 1811 Merrill (10.1016/j.chroma.2013.10.064_bib0010) 2009; 50 Farwanah (10.1016/j.chroma.2013.10.064_bib0185) 2011; 1811 Ryland (10.1016/j.chroma.2013.10.064_bib0045) 2011; 11 Liang (10.1016/j.chroma.2013.10.064_bib0175) 2013; 1294 Fahy (10.1016/j.chroma.2013.10.064_bib0005) 2005; 46 Groener (10.1016/j.chroma.2013.10.064_bib0070) 2007; 53 Masood (10.1016/j.chroma.2013.10.064_bib0115) 2012; 47 |
References_xml | – volume: 1811 start-page: 68 year: 2011 ident: bib0155 publication-title: BBA – Mol. Cell Biol. – volume: 50 start-page: S97 year: 2009 ident: bib0010 publication-title: J. Lipid Res. – volume: 64 start-page: 2270 year: 2007 ident: bib0020 publication-title: Cell. Mol. Life Sci. – volume: 1294 start-page: 58 year: 2013 ident: bib0175 publication-title: J. Chromatogr. A – volume: 7 start-page: 4982 year: 2008 ident: bib0135 publication-title: J. Proteome Res. – volume: 6 start-page: 3291 year: 2007 ident: bib0140 publication-title: J. Proteome Res. – volume: 51 start-page: 3074 year: 2010 ident: bib0150 publication-title: J. Lipid Res. – volume: 46 start-page: 839 year: 2005 ident: bib0005 publication-title: J. Lipid Res. – volume: 4 start-page: 604 year: 2004 ident: bib0200 publication-title: Nat. Rev. Cancer – volume: 111 start-page: 6387 year: 2011 ident: bib0030 publication-title: Chem. Rev. – volume: 293 start-page: 204 year: 2001 ident: bib0055 publication-title: Anal. Biochem. – volume: 1811 start-page: 854 year: 2011 ident: bib0185 publication-title: BBA – Mol. Cell Biol. – volume: 275 start-page: 17221 year: 2000 ident: bib0015 publication-title: J. Biol. Chem. – volume: 164 start-page: 590 year: 2011 ident: bib0040 publication-title: Chem. Phys. Lipids – volume: 18 start-page: 577 year: 2004 ident: bib0145 publication-title: Rapid Commun. Mass Spectrom. – volume: 9 start-page: 139 year: 2008 ident: bib0025 publication-title: Nat. Rev. Mol. Cell Biol. – volume: 50 start-page: 1692 year: 2009 ident: bib0095 publication-title: J. Lipid Res. – volume: 39 start-page: 82 year: 2006 ident: bib0085 publication-title: Methods – volume: 6 start-page: 1603 year: 2010 ident: bib0195 publication-title: Future Oncol. – volume: 11 start-page: 138 year: 2011 ident: bib0045 publication-title: Cancer Biol. Ther. – volume: 1298 start-page: 9 year: 2013 ident: bib0170 publication-title: J. Chromatogr. A – start-page: 185 year: 2010 ident: bib0210 publication-title: Sphingolipids as Signaling and Regulatory Molecules – volume: 423 start-page: 187 year: 2012 ident: bib0110 publication-title: Anal. Biochem. – volume: 51 start-page: 1643 year: 2010 ident: bib0050 publication-title: J. Lipid Res. – volume: 843 start-page: 327 year: 2006 ident: bib0075 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. – volume: 47 start-page: 209 year: 2012 ident: bib0115 publication-title: Lipids – volume: 928 start-page: 22 year: 2013 ident: bib0180 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. – volume: 84 start-page: 403 year: 2012 ident: bib0165 publication-title: Anal. Chem. – volume: 340 start-page: 113 year: 2005 ident: bib0060 publication-title: Anal. Biochem. – volume: 51 start-page: 2001 year: 2010 ident: bib0105 publication-title: J. Lipid Res. – volume: 32 start-page: 1795 year: 2009 ident: bib0065 publication-title: Arch. Pharm. Res. – volume: 51 start-page: 641 year: 2010 ident: bib0120 publication-title: J. Lipid Res. – volume: 877 start-page: 2976 year: 2009 ident: bib0090 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. – volume: 49 start-page: 1137 year: 2008 ident: bib0130 publication-title: J. Lipid Res. – volume: 29 start-page: 381 year: 2008 ident: bib0035 publication-title: Endocr. Rev. – volume: 401 start-page: 154 year: 2010 ident: bib0100 publication-title: Anal. Biochem. – volume: 371 start-page: 135 year: 2007 ident: bib0160 publication-title: Anal. Biochem. – volume: 53 start-page: 742 year: 2007 ident: bib0070 publication-title: Clin. Chem. – volume: 12 start-page: 285 year: 2012 ident: bib0205 publication-title: Anti-Cancer Agents Med. – volume: 30 start-page: 567 year: 2011 ident: bib0190 publication-title: Cancer Metastasis Rev. – volume: 36 start-page: 207 year: 2005 ident: bib0080 publication-title: Methods – volume: 37 start-page: 911 year: 1959 ident: bib0125 publication-title: Can. J. Biochem. Physiol. – volume: 11 start-page: 138 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0045 publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.11.2.14624 – volume: 36 start-page: 207 year: 2005 ident: 10.1016/j.chroma.2013.10.064_bib0080 publication-title: Methods doi: 10.1016/j.ymeth.2005.01.009 – volume: 1294 start-page: 58 year: 2013 ident: 10.1016/j.chroma.2013.10.064_bib0175 publication-title: J. Chromatogr. A doi: 10.1016/j.chroma.2013.04.016 – volume: 18 start-page: 577 year: 2004 ident: 10.1016/j.chroma.2013.10.064_bib0145 publication-title: Rapid Commun. Mass Spectrom. doi: 10.1002/rcm.1373 – volume: 1298 start-page: 9 year: 2013 ident: 10.1016/j.chroma.2013.10.064_bib0170 publication-title: J. Chromatogr. A doi: 10.1016/j.chroma.2013.05.019 – volume: 877 start-page: 2976 year: 2009 ident: 10.1016/j.chroma.2013.10.064_bib0090 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2009.07.008 – volume: 29 start-page: 381 year: 2008 ident: 10.1016/j.chroma.2013.10.064_bib0035 publication-title: Endocr. Rev. doi: 10.1210/er.2007-0025 – volume: 50 start-page: S97 year: 2009 ident: 10.1016/j.chroma.2013.10.064_bib0010 publication-title: J. Lipid Res. doi: 10.1194/jlr.R800073-JLR200 – volume: 51 start-page: 641 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0120 publication-title: J. Lipid Res. doi: 10.1194/jlr.D000430 – volume: 51 start-page: 3074 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0150 publication-title: J. Lipid Res. doi: 10.1194/jlr.D008532 – volume: 6 start-page: 3291 year: 2007 ident: 10.1016/j.chroma.2013.10.064_bib0140 publication-title: J. Proteome Res. doi: 10.1021/pr070183p – volume: 50 start-page: 1692 year: 2009 ident: 10.1016/j.chroma.2013.10.064_bib0095 publication-title: J. Lipid Res. doi: 10.1194/jlr.D800051-JLR200 – volume: 46 start-page: 839 year: 2005 ident: 10.1016/j.chroma.2013.10.064_bib0005 publication-title: J. Lipid Res. doi: 10.1194/jlr.E400004-JLR200 – volume: 84 start-page: 403 year: 2012 ident: 10.1016/j.chroma.2013.10.064_bib0165 publication-title: Anal. Chem. doi: 10.1021/ac202646v – volume: 423 start-page: 187 year: 2012 ident: 10.1016/j.chroma.2013.10.064_bib0110 publication-title: Anal. Biochem. doi: 10.1016/j.ab.2012.01.027 – volume: 51 start-page: 1643 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0050 publication-title: J. Lipid Res. doi: 10.1194/jlr.R003996 – volume: 164 start-page: 590 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0040 publication-title: Chem. Phys. Lipids doi: 10.1016/j.chemphyslip.2011.04.013 – volume: 12 start-page: 285 year: 2012 ident: 10.1016/j.chroma.2013.10.064_bib0205 publication-title: Anti-Cancer Agents Med. doi: 10.2174/187152012800228643 – volume: 47 start-page: 209 year: 2012 ident: 10.1016/j.chroma.2013.10.064_bib0115 publication-title: Lipids doi: 10.1007/s11745-011-3633-2 – volume: 275 start-page: 17221 year: 2000 ident: 10.1016/j.chroma.2013.10.064_bib0015 publication-title: J. Biol. Chem. doi: 10.1074/jbc.R000005200 – volume: 111 start-page: 6387 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0030 publication-title: Chem. Rev. doi: 10.1021/cr2002917 – volume: 7 start-page: 4982 year: 2008 ident: 10.1016/j.chroma.2013.10.064_bib0135 publication-title: J. Proteome Res. doi: 10.1021/pr800373m – volume: 6 start-page: 1603 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0195 publication-title: Future Oncol. doi: 10.2217/fon.10.116 – volume: 51 start-page: 2001 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0105 publication-title: J. Lipid Res. doi: 10.1194/jlr.D005322 – volume: 340 start-page: 113 year: 2005 ident: 10.1016/j.chroma.2013.10.064_bib0060 publication-title: Anal. Biochem. doi: 10.1016/j.ab.2005.01.058 – volume: 30 start-page: 567 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0190 publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-011-9304-1 – volume: 32 start-page: 1795 year: 2009 ident: 10.1016/j.chroma.2013.10.064_bib0065 publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-009-2219-5 – volume: 64 start-page: 2270 year: 2007 ident: 10.1016/j.chroma.2013.10.064_bib0020 publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-007-7076-0 – start-page: 185 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0210 – volume: 9 start-page: 139 year: 2008 ident: 10.1016/j.chroma.2013.10.064_bib0025 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2329 – volume: 371 start-page: 135 year: 2007 ident: 10.1016/j.chroma.2013.10.064_bib0160 publication-title: Anal. Biochem. doi: 10.1016/j.ab.2007.08.019 – volume: 1811 start-page: 854 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0185 publication-title: BBA – Mol. Cell Biol. doi: 10.1016/j.bbalip.2011.05.011 – volume: 53 start-page: 742 year: 2007 ident: 10.1016/j.chroma.2013.10.064_bib0070 publication-title: Clin. Chem. doi: 10.1373/clinchem.2006.079012 – volume: 37 start-page: 911 year: 1959 ident: 10.1016/j.chroma.2013.10.064_bib0125 publication-title: Can. J. Biochem. Physiol. doi: 10.1139/o59-099 – volume: 49 start-page: 1137 year: 2008 ident: 10.1016/j.chroma.2013.10.064_bib0130 publication-title: J. Lipid Res. doi: 10.1194/jlr.D700041-JLR200 – volume: 843 start-page: 327 year: 2006 ident: 10.1016/j.chroma.2013.10.064_bib0075 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2006.06.025 – volume: 39 start-page: 82 year: 2006 ident: 10.1016/j.chroma.2013.10.064_bib0085 publication-title: Methods doi: 10.1016/j.ymeth.2006.05.004 – volume: 1811 start-page: 68 year: 2011 ident: 10.1016/j.chroma.2013.10.064_bib0155 publication-title: BBA – Mol. Cell Biol. doi: 10.1016/j.bbalip.2010.11.003 – volume: 928 start-page: 22 year: 2013 ident: 10.1016/j.chroma.2013.10.064_bib0180 publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2013.03.019 – volume: 401 start-page: 154 year: 2010 ident: 10.1016/j.chroma.2013.10.064_bib0100 publication-title: Anal. Biochem. doi: 10.1016/j.ab.2010.02.023 – volume: 4 start-page: 604 year: 2004 ident: 10.1016/j.chroma.2013.10.064_bib0200 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1411 – volume: 293 start-page: 204 year: 2001 ident: 10.1016/j.chroma.2013.10.064_bib0055 publication-title: Anal. Biochem. doi: 10.1006/abio.2001.5108 |
SSID | ssj0017072 ssj0029838 |
Score | 2.28728 |
Snippet | •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum... Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 103 |
SubjectTerms | alkaline hydrolysis bioactive properties Biological and medical sciences biomarkers blood serum Carcinoma, Hepatocellular - blood cell membranes ceramides Chromatography, Reverse-Phase - methods detection limit hepatoma homeostasis Host-tumor relations. Immunology. Biological markers human diseases Humans Lipidomics Liquid chromatography–mass spectrometry Liver Neoplasms - blood mass spectrometry Medical sciences monitoring Multiple reaction monitoring Reproducibility of Results reversed-phase liquid chromatography screening Serum Sphingolipid profiling Sphingolipids - blood sphingomyelins Tandem Mass Spectrometry - methods Tert-butyl methyl ether Tumors |
Title | Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma |
URI | https://dx.doi.org/10.1016/j.chroma.2013.10.064 https://www.ncbi.nlm.nih.gov/pubmed/24210299 https://www.proquest.com/docview/1635025462 https://www.proquest.com/docview/1694493479 |
Volume | 1320 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWywEkhHhTHtUgcc1ukzh-cFtVrAqlFUKs6C1KbIcGtUno48CFX8sPYSZOuuxhWYlTFcvjuO6X8dT5Zj7G3tjYqUSFPNBGuIBnhQnyKJLBSOVa5aGIsjaLfzYXkwv-YZEsjti4z4UhWmXn-71Pb71113LareZpU5aU44tPm5AxeuFQqHhBGexcEspPfh1oHqEcyUM9qUir2Ltm4iWgaZ9L1xK-zHJTt6WIwviECF-CX7dX3W2yLa5g4aUvro9N2z3q_D671wWXcObn_4Adueohuz3uNd0esd8fifgd0LDOQqvPB4jB_Rq2DR1F1auyKS14IW-8hvwnEDP-G1Clp83W2aBZ4r4Hq_LHHjv6L7Pryl6DqfcNDUyHu2C91j30lEUcwidRwLr1I3SgCHUBawzfoU34pMoJOM23MGtlrcFeEpogqyz89bIdygqWuJPuanrzQFRaMKSKVOF0HrOL83dfxpOg03kIDE_ULhDKamezxEZFZLNCGcNVYoWO8jzJiyg2BWmiJ3EeKlMYVwiFFlw6I0a80NLFT9hxVVfuGYO8sKPIWq3QiksusqQtkTfK4owq27sBi_tfNDVdEXTS4lilPdvte-qXLiUcUCviYMCCg1Xji4Dc0F_2YEmvgDnFfeoGy-EVbB1uF0ktMfbGDq97sKWIHVrjrHL1fptiYJ1QaQMR_auP5lxT8vCAPfVIvbwDp3__Wj__78m_YHfoisg-YfySHe82e_cKQ7ZdPmyfySG7dfZ-OpnT5_Tz1ym2zj_N_gBKXkp5 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELWW5bBICPFN-VgGiWt2G8dxbG6oYlWg3dOu1FuU2A4NapPQNgcu_Fp-CDNx0mUPy0ocm3ocxx2Pp86b9xh7byOnYhWKQBvpApEVJsg5T4KxyrXKQ8mzrop_fi6nl-LLIl4csMlQC0Owyj72-5jeRev-ymk_m6dNWVKNL642mUQYhUOposUddlfg8iUZg5Nfe5xHmIyTPaEU1yrysZmACWg7FNN1iC-z3NQdF1EYnRDiS4qbNqv7TbbFKSy89sXNyWm3SZ09ZA_67BI--gd4xA5c9ZgdTQZRtyfs94yQ3wF16yx0An2ATtiuYdvQWVS9KpvSglfyxs-Q_wSCxn8DonrabJ0NmiVufLAqf7TY0D_Mrue9BlO3DXVMp7tgvdg9DJhF7MJXUcC6CyR0ogh1AWvM36Gr-CTqBBzmB5h3utZgrxBNkFUW_nrbDmUFS9xKdzW9eiAsLRiSRapwOE_Z5dmni8k06IUeAiNitQukstrZLLa84DYrlDFCxVZqnudxXvDIFCSKHkd5qExhXCEVWojEGTkWhU5c9IwdVnXlXjDICzvm1mqFViIRMos7jrxxFmVEbe9GLBp-0dT0LOgkxrFKB7jb99RPXUp-QFfRD0Ys2Fs1ngXklvbJ4CzpNW9OcaO6xfL4mm_tb8cTnWDyjQ3eDc6Wou_QHGeVq9ttipl1TNwGkv-rjRZCU_XwiD33nnp1B0F__7V--d-Df8uOphfzWTr7fP71FbtH3xDyJ4xes8PdpnVvMH_b5cfd-vwDWppJWA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Large-scaled+human+serum+sphingolipid+profiling+by+using+reversed-phase+liquid+chromatography+coupled+with+dynamic+multiple+reaction+monitoring+of+mass+spectrometry%3A+Method+development+and+application+in+hepatocellular+carcinoma&rft.au=Li%2C+Jia&rft.au=Hu%2C+Chunxiu&rft.au=Zhao%2C+Xinjie&rft.au=Dai%2C+Weidong&rft.date=2013-12-13&rft.issn=0021-9673&rft.volume=1320+p.103-110&rft.spage=103&rft.epage=110&rft_id=info:doi/10.1016%2Fj.chroma.2013.10.064&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9673&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9673&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9673&client=summon |